Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, April 24, 2024.
Statera Biopharma, Inc. (NASDAQ:STAB)
Long-Term Uptrend (+90) - STAB is in a strong uptrend that is likely to continue. While STAB is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid STAB?
MarketClub looks at technical strength and momentum to determine if the timing is right for STAB.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for STAB
The long-term trend has been UP since Apr 19th, 2024 at 0.0006
The intermediate-term trend has been UP since Nov 28th, 2023 at 0.0001
The short-term trend has been UP since Apr 19th, 2024 at 0.0006
Smart Scan Analysis for STAB
Based on our trend formula, STAB is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 0.0007 | 0.0007 | 0.0007 | 0.0007 | 0.0000 |
| Prev. Close | Volume | Bid | Ask | Time |
| 0.0007 | 5000 | 2024-04-24 12:15:47 |
| 52wk High | 0.038 | 52wk High Date | 2023-07-10 |
| 52wk Low | 0.000001 | 52wk Low Date | 2024-01-04 |
| Average Volume | 7,292 | Shares Outstanding | 54,662 |
| Assets | 12,749,125M | Liabilities | 22,990,420M |
| P/E Ratio | -0.01980000 |